Drug and device safety

Everyone’s tough on drugs again

by

Traffickers are to blame, the candidates say. Virtually no one’s talking about treatment.

French lawmaker admits police caught him buying drugs

by

Andy Kerbrat of the New Popular Front said he will seek help for addiction following the news.

Paris threatens millions in penalties if paracetamol-maker leaves France after US takeover

by

The deal has faced intense, cross-party scrutiny in Paris.

Meet Elon Musk’s man in Washington

by

The SpaceX billionaire is forging new ties with a federal telecom official who could help funnel billions of dollars to his company if Trump is elected.

Bart De Wever: The man who wants to destroy Belgium reluctantly heads toward running it

by

How do you rule a country that you’ve spent your life trying to split up? 

Paris seeks to calm Sanofi workers’ fears over American takeover

by

French government threatens sanctions if production leaves France; downplays vetoing the deal.

Building a future-proof regulatory system

by

Simpler, faster, better – let’s not miss the opportunity to revamp the EU pharmaceutical regulatory framework to transform lives.

Establishing criteria for unmet medical needs: let’s not leave people living with chronic diseases behind

by

The narrow definition of unmet medical need used in the General Pharmaceutical Legislation may hinder rather than help efforts to find new treatments.

Macron and Trudeau: The downfall of a pair of liberal bros

by

As the French president visits Canada, both he and Trudeau are grappling with declining popularity and the rise of right-wing movements that challenge their political legacies.

Only bold reform will expand access to innovative medicines in the UK

by

Greater collaboration between industry, government, policymakers and the NHS will be critical for treatment options in the UK to match the pace of scientific innovation. What is our route to achieving timely patient access across the country like our European neighbours?

Donald Trump’s unlikely weed wager

by

The former president’s pro-cannabis policies could bolster his efforts to gain support with key Democratic constituencies.

Where Harris chooses to campaign tells an important story about her strategy

by

Johnstown, Wilkes-Barre and Pittsburgh: A POLITICO analysis of campaign stops tells a story about how the vice president thinks she can win.

Newborns face deadly infections amid superbug crisis

by

Clinicians are looking into the potential of probiotics to prevent infections.

Can global leaders agree on a tough AMR plan?

by

Some experts lament the lack of bolder commitments in farming.

These are the most deadly pathogens — so why aren’t drug companies targeting them?

by

Despite calls to step up efforts, investment in antimicrobial resistance is still insufficient.

Wars are breeding superbugs that will spread ‘everywhere’

by

Drug-resistant infections thrive in the chaos of war, spilling over to neighboring regions.

Guns, migrants, oil: Is it possible to oust Venezuela’s regime?

by

Nicolás Maduro doesn’t care about your evidence or your condemnations.

‘Nobody in Politics Is Able to Say It’: The Truth About Latino Voters

by

A top political strategist explains how the Latino vote is shifting.

David Cameron’s barefoot warrior bids for glory in California

by

Britain’s disrupter-in-chief and Trump admirer now has his eye on the Golden State’s governor’s mansion.

As France cracks down on Telegram, EU sits on the sidelines

by

Europe has moved slowly to regulate Pavel Durov’s social media app.

Trump’s pledge to be ‘great for women and their reproductive rights’ angers advocates

by

The former president invoked language more commonly used by Democrats, and anti-abortion advocates quickly took notice of his tonal shift.

9 times politicians reached for Ozempic — or more trad diets

by

From Ozempic to “bulletproof” coffee, politicians are just like the rest of us when it comes to seeking a shortcut to slim.

9 times politicians reached for Ozempic — or more trad diets

by

From Ozempic to “bulletproof” coffee, politicians are just like the rest of us when it comes to seeking a shortcut to slim.

Dems defend Harris’ economic policy but don’t go all in on price-gouging

by

Kentucky Gov. Andy Beshear was alone in discussing the particulars of a policy designed to stop price gouging.

What the last of the anti-war Chicago Seven wants today’s protestors to know

by

Lee Weiner helped lead the protests in 1968. Now he’s smoking weed in Ron DeSantis’ hometown.

Key drug doesn’t work against deadly new mpox virus, study finds

by

The findings are “disappointing,” said Jeanne Marrazzo, director of the U.S. National Institute of Allergy and Infectious Diseases.

Trump says he’s ‘entitled to personal attacks’ on Harris

by

Over and over, Trump went after Harris personally — a tactic top allies have cautioned against him doing.

The 5 major questions facing Kamala Harris now

by

The vice president has a number of pitfalls ahead.

Researchers cast doubt over benefits of new Alzheimer’s therapies

by

Lecanemab and donanemab are two of the most recent medicines to treat Alzheimer’s disease.

Washington’s most powerful interests don’t know whether to cheer Harris — or dread her

by

Would she bring continuity with Joe Biden’s policies? A more centrist vibe? A sharper progressive bite? Industries including tech, energy and pharma want to know.

EU drugs regulator revises rules after court links experts to industry

by

A court found flaws in the European Medicines Agency’s policy for handling links to competitor drugs.

To do: 6 thorny issues lurking in MEPs’ inboxes

by

From creating an EU-wide money market to protecting kids online, POLITICO looks at what lies ahead for lawmakers.

Who is Keir Starmer? Britain’s incoming prime minister is complex, unknowable, aggrieved

by

A trip north with the U.K.’s most powerful leader in a generation.

Ozempic-maker blasts Biden in price row

by

Novo Nordisk has denied U.S. president’s claim it is “ripping off” consumers, saying the reality isn’t so simple.

Europe is running out of heroin. The alternatives are much worse

by

Nitazines from China are penetrating Europe, causing almost 100 deaths in Latvia and Estonia last year.

Belgium’s make-or-break election, explained

by

A triple vote could shake up Belgian politics, or drive it into gridlock.

Manhunt underway in France after two officers killed in prisoner escape

by

Ambush by gunmen armed with “heavy weapons” comes as a French senate report says the country is being “submerged” in drugs-related crime.

Sánchez on the edge: Will Spain’s prime minister resign?

by

His ultimate decision could result in very different scenarios for Spain, and could impact negotiations over the new leaders of the EU’s institutions.

Strong intellectual property is critical to competitive edge

by

European intellectual property policies are weakening Europe’s competitive edge at the very moment that EU leaders have recognized the importance of restoring the region’s status as a global economic superpower.

Weight loss drugs like Ozempic not linked with suicidal thoughts, EU drugs regulator finds

by

There is no evidence to suggest a link between the use of weight loss drugs like Ozempic and suicidal thoughts, the EU’s drugs regulator has found. The European Medicines Agency (EMA)’s drug safety committee, PRAC, evaluated the risk of possible side effects in people who have used a class of drugs known as GLP-1, after […]

EU pitches new pharma bonus to cure rare diseases. But will it work? 

by

While DNA-altering treatments promise to cure many rare diseases, they might not qualify for planned bonuses. 

Why Portland failed where Portugal succeeded in decriminalizing drugs

by

Oregon lawmakers gave it three years. Portugal’s program took longer to show results.

Macron rattled as EU election defeat looms

by

Macron cracks the whip as his EU campaign stutters amid a widening gap between centrists and the far right.

Dutch drug criminals overrun port of Antwerp, top prosecutor says

by

“At one point in 2022, it was so bad that an entire wing of the Antwerp prison was full of Dutch people,” said Franky De Keyzer.

Netanyahu denies Palestinians are starving

by

Numerous world leaders and humanitarian charities have criticized Israel for not letting enough food aid into Gaza.

Europe’s drug gangs open ‘torture rooms,’ arm kids with Kalashnikovs, EU agencies warn

by

The massive narcotics trade across the continent is fueling ‘unprecedented’ levels of violence.

Scientific progress: A look ahead

by

What two decades of progress in medicine development tells us about the next 20 years.

Can anyone stop Britain’s Tories going full Trump?

by

UK centrist Conservatives are in search of a leader to stop the right hijacking the party after the election.

10 ways a second Trump term could be more extreme than the first

by

From nationwide abortion bans to classroom culture wars, assaults on climate science and political weaponization of the military, his return to the White House could make Trump 1.0 seem tame.

The Biden name: How the president’s brother became embroiled in a hospital fiasco

by

Jim Biden played a major role in a company called Americore, which the government has accused of massive Medicare fraud.

30 Things Joe Biden Did as President You Might Have Missed

by

Drone armies, expanded overtime pay and over-the-counter birth control pills are just some of the new things Biden has ushered in as president that you might not have heard about.

Biden’s got pharma’s back in global pandemic treaty negotiations

by

Negotiators on a treaty to guide the world’s response to the next pandemic oppose any requirement to share drugmakers’ intellectual property.

EU funds first psychedelic study, in patients with incurable diseases

by

Magic mushrooms trial gets underway.

Zelenskyy condemns surveillance of Ukraine investigative journalists

by

The National Police and the Security Service of Ukraine have started separate probes into incidents of pressure on journalists.

A starring role for NASA in Biden’s push to end cancer

by

Astronauts aboard the International Space Station are using microgravity to unlock the disease’s secrets.

Politicians behaving badly: 6 times partying politicos went too far

by

Remember Partygate, Pipigate, bunga bunga and the Brussels lockdown orgy?!

Hydroxychloroquine could have caused 17,000 deaths during COVID, study finds

by

Former US President Donald Trump said: ‘What do you have to lose? Take it.’

Unlocked: Top 10 behind-the-paywall stories of 2023

by

A Christmas gift for all the policy wonks out there.

Meet the moment: Don’t set back the clock on patients

by

A wave of concerning policies around the globe that are currently being implemented or are under discussion will, if the trend continues, have a profoundly negative impact on patients.

Hunter Biden charged with nine criminal counts for allegedly failing to pay taxes

by

The president’s son may now face two criminal trials in 2024.

Let HIV communities lead

by

Ongoing HIV stigma hampers testing, treatment and prevention. Multilayered impacts necessitate community initiatives and the dismantling of discriminatory laws for effective collaboration, which are essential for achieving HIV elimination goals.

Taking medicines from bench to bedside

by

The ongoing review of the EU Pharmaceutical Legislation is looking at recalibrating IP incentives. Intellectual Property fuels medical innovations from the research bench to the patient’s bedside.

Belgium leads the charge on the EU’s medicines reshoring plans

by

New European drug factories will be greener and more efficient than the old ones — and their products more expensive.

Transforming HIV prevention in Europe

by

Pre-exposure prophylaxis, or PrEP, has revolutionized HIV prevention. New technologies, including injectables, wider availability and the reduction of stigma are the next frontier.

Moscow police raid gay clubs after high court labels LGBTQ+ movement ‘extremist’

by

The crackdown follows the effective ban of the LGBTQ+ movement by the Russian Supreme Court.

‘Grandpa Joe:’ Biden campaign facing heat over plans to deal with his age

by

Everyone recognizes there’s an issue. Not everyone thinks it’s critical. And there is no consensus on the best way to approach it.

Belgium in race to burn seized cocaine before gangs steal it back

by

The country’s drugs commissioner will present a plan to tackle drug-related crimes to Belgium’s National Security Council on Wednesday.

Campaigners sound conflict of interest alarm over MEP couple, missing pharma report

by

The romantic relationship between Pernille Weiss and Christian Ehler has raised questions about why an independent study was taken offline.

The mysterious case of the MEP lovers and the disappearing EU pharma report

by

A European Parliament study that centers on the delicate topic of incentives for drug companies was published, then pulled offline again, pending further queries from MEPs.

Biosimilar matters

by

Why we should stop devaluing biosimilar medicines at all costs.

Sweeping new Biden order aims to alter the AI landscape

by

The White House is poised to make an all-hands effort to impose national rules on a fast-moving technology, according to a draft executive order.

Agile regulatory rules vital to foster future innovation

by

Medicines, diagnostics and AI can combine to save lives — here’s how to ensure new products reach patients without compromising on safety.

Elevating innovation through partnerships

by

Ricardo Marek, President Europe & Canada, Takeda Pharmaceuticals, shares these insights with POLITICO Studio.

Fake Ozempic: Several people hospitalized in Austria

by

Crime agency says individuals taking the counterfeit product to lose weight could have died without immediate treatment.

Seeing more than HIV: A person-centered approach to HIV care 

by

There’s more to the experience of living with HIV than suppressing the virus. Listening, valuing and integrating patient voices in HIV care is critical to leave no one behind. 

What’s in a name? Why unmet medical needs are riling the pharma industry 

by

The EU wants to steer drug development to cover research gaps, but industry hates the idea.

What single market? Why Romanians get new medicines 2 years after Germans

by

Not all patients are equal when it comes to treatment with cutting-edge drugs.

Why dengue in Europe could spell disaster for the rest of the world 

by

Increased investment into previously neglected diseases could see poorer countries left behind.

Arrive at Gare du Midi, then run! How to navigate Brussels

by

From confusing and dangerous train stations to scooters dumped in a pile, Brussels has all your transport needs covered.

Keir Starmer says no to UK drugs reform

by

Opposition Labour Party leader says if he comes to power, his government would be focused on the 5 missions he has already set out.

Severe asthma — breaking the cycle of inadequate care

by

The real cost of severe asthma: Why urgent action is needed to protect patients and reduce the strain on stretched health systems.

UK confirms fifth delay to post-Brexit border checks

by

The new checks on some food and animal products coming from the EU will now begin in January.

Teen vaping: Did the EU get it wrong on e-cigarettes?

by

An explosion in vaping rates among kids is prompting Europe to rethink its approach to regulation.

Drug-resistant killer bugs linked to air pollution, top scientists say

by

Study findings have ‘substantial policy and environmental implications,’ researchers say. But other academics aren’t so sure.

9 ways Dutch political paralysis hits the EU

by

Political limbo likely to hold back the Netherlands’ influence on key files in Brussels.

Why Big Pharma might think twice about running away to America

by

A major drug pricing crackdown in the US is threatening drug companies’ bottom lines.

AI improves breast cancer detection rate by 20 percent

by

Results from a study in Sweden show the potential of using artificial intelligence in mammography.

Finnegas BETA

An Eccentri(; Enterprise